SNN
Price
$36.27
Change
+$0.77 (+2.17%)
Updated
Aug 7, 10:55 AM (EDT)
Capitalization
10.95B
91 days until earnings call
SONVY
Price
$54.59
Change
-$0.26 (-0.47%)
Updated
Aug 6 closing price
Capitalization
16.61B
Interact to see
Advertisement

SNN vs SONVY

Header iconSNN vs SONVY Comparison
Open Charts SNN vs SONVYBanner chart's image
Smith & Nephew
Price$36.27
Change+$0.77 (+2.17%)
Volume$500
Capitalization10.95B
Sonova Holding AG
Price$54.59
Change-$0.26 (-0.47%)
Volume$11.88K
Capitalization16.61B
SNN vs SONVY Comparison Chart in %
Loading...
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNN vs. SONVY commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNN is a Hold and SONVY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (SNN: $35.50 vs. SONVY: $54.59)
Brand notoriety: SNN and SONVY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SNN: 139% vs. SONVY: 39%
Market capitalization -- SNN: $10.95B vs. SONVY: $16.61B
SNN [@Medical Specialties] is valued at $10.95B. SONVY’s [@Medical Specialties] market capitalization is $16.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNN’s FA Score shows that 1 FA rating(s) are green whileSONVY’s FA Score has 1 green FA rating(s).

  • SNN’s FA Score: 1 green, 4 red.
  • SONVY’s FA Score: 1 green, 4 red.
According to our system of comparison, both SNN and SONVY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNN’s TA Score shows that 5 TA indicator(s) are bullish while SONVY’s TA Score has 4 bullish TA indicator(s).

  • SNN’s TA Score: 5 bullish, 4 bearish.
  • SONVY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNN is a better buy in the short-term than SONVY.

Price Growth

SNN (@Medical Specialties) experienced а +14.78% price change this week, while SONVY (@Medical Specialties) price change was -0.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.15%. For the same industry, the average monthly price growth was -1.00%, and the average quarterly price growth was -2.66%.

Reported Earning Dates

SNN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.15% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SONVY($16.6B) has a higher market cap than SNN($10.9B). SNN has higher P/E ratio than SONVY: SNN (40.76) vs SONVY (22.22). SNN YTD gains are higher at: 46.814 vs. SONVY (-14.603). SONVY (979M) and SNN (956M) have comparable annual earnings (EBITDA) . SNN has higher revenues than SONVY: SNN (5.55B) vs SONVY (3.74B).
SNNSONVYSNN / SONVY
Capitalization10.9B16.6B66%
EBITDA956M979M98%
Gain YTD46.814-14.603-321%
P/E Ratio40.7622.22183%
Revenue5.55B3.74B148%
Total Cash302MN/A-
Total Debt3.08BN/A-
FUNDAMENTALS RATINGS
SNN vs SONVY: Fundamental Ratings
SNN
SONVY
OUTLOOK RATING
1..100
8764
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
9170
SMR RATING
1..100
9447
PRICE GROWTH RATING
1..100
4079
P/E GROWTH RATING
1..100
8367
SEASONALITY SCORE
1..100
5037

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (7) in the Medical Specialties industry is in the same range as SONVY (9) in the null industry. This means that SNN’s stock grew similarly to SONVY’s over the last 12 months.

SONVY's Profit vs Risk Rating (70) in the null industry is in the same range as SNN (91) in the Medical Specialties industry. This means that SONVY’s stock grew similarly to SNN’s over the last 12 months.

SONVY's SMR Rating (47) in the null industry is somewhat better than the same rating for SNN (94) in the Medical Specialties industry. This means that SONVY’s stock grew somewhat faster than SNN’s over the last 12 months.

SNN's Price Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for SONVY (79) in the null industry. This means that SNN’s stock grew somewhat faster than SONVY’s over the last 12 months.

SONVY's P/E Growth Rating (67) in the null industry is in the same range as SNN (83) in the Medical Specialties industry. This means that SONVY’s stock grew similarly to SNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNNSONVY
RSI
ODDS (%)
Bearish Trend 1 day ago
36%
Bullish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 1 day ago
43%
Bearish Trend 1 day ago
61%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
54%
Bearish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 16 days ago
64%
Declines
ODDS (%)
Bearish Trend 8 days ago
60%
Bearish Trend 1 day ago
58%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
62%
Aroon
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
GBPAUD2.050.00
+0.05%
United Kingdom Pound - Australian Dollar
GCIEX7.44N/A
N/A
Gabelli Equity Income I
HFAJX15.66N/A
N/A
Hartford Schroders Intl Cntrrn Val A
USDGBP0.75-0.00
-0.01%
United States Dollar - United Kingdom Pound
JPYCHF0.55-0.00
-0.53%
Japan Yen - Switzerland Franc

SNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNN has been loosely correlated with SYK. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNN
1D Price
Change %
SNN100%
+0.06%
SYK - SNN
43%
Loosely correlated
-1.55%
STAA - SNN
42%
Loosely correlated
-0.44%
ALC - SNN
39%
Loosely correlated
-1.66%
TFX - SNN
38%
Loosely correlated
-2.42%
SONVY - SNN
37%
Loosely correlated
-0.47%
More

SONVY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONVY has been loosely correlated with ALC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SONVY jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONVY
1D Price
Change %
SONVY100%
-0.47%
ALC - SONVY
51%
Loosely correlated
-1.66%
SAUHY - SONVY
48%
Loosely correlated
N/A
AORT - SONVY
42%
Loosely correlated
+0.37%
SNN - SONVY
40%
Loosely correlated
+0.06%
OFIX - SONVY
39%
Loosely correlated
+1.87%
More